From development to clinical success: the journey of established and next-generation BTK inhibitors
Shivani Gupta, Arpit Sharma, Alok Kumar Shukla, Abha Mishra, Amit Kumar Singh
Topics & Concepts
Bruton's tyrosine kinaseIbrutinibChronic lymphocytic leukemiaMantle cell lymphomaMedicineCancer researchLymphomaTyrosine kinasebreakpoint cluster regionB cellTargeted therapyImmunologyLeukemiaInternal medicineCancerReceptorAntibodyChronic Lymphocytic Leukemia ResearchImmunodeficiency and Autoimmune DisordersPI3K/AKT/mTOR signaling in cancer